The Food and Drug Administration placed Geron Corp.'s (Nasdaq: GERN) Investigational New Drug Application for imetelstat on full clinical hold sending the stock price plummeting $2.76 to $1.64.
Geron Drug Place On Hold
March 12, 2014 at 14:34 PM EDT
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.